(2S,4S)-4-(4-(2-aminothiazolo[5,4-b]pyridin-5-yl)-1H-1,2,3-triazol-1-yl)-N-(2,4-dichlorophenyl)pyrrolidine-2-carboxamide

ID: ALA5207617

Chembl Id: CHEMBL5207617

PubChem CID: 168295455

Max Phase: Preclinical

Molecular Formula: C19H16Cl2N8OS

Molecular Weight: 475.37

Associated Items:

Names and Identifiers

Canonical SMILES:  Nc1nc2ccc(-c3cn([C@@H]4CN[C@H](C(=O)Nc5ccc(Cl)cc5Cl)C4)nn3)nc2s1

Standard InChI:  InChI=1S/C19H16Cl2N8OS/c20-9-1-2-12(11(21)5-9)24-17(30)15-6-10(7-23-15)29-8-16(27-28-29)13-3-4-14-18(25-13)31-19(22)26-14/h1-5,8,10,15,23H,6-7H2,(H2,22,26)(H,24,30)/t10-,15-/m0/s1

Standard InChI Key:  RIXBMLAVFFOVIP-BONVTDFDSA-N

Alternative Forms

  1. Parent:

    ALA5207617

    ---

Associated Targets(Human)

ABL1 Tclin Bcr/Abl fusion protein (1667 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
K562 (73714 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
K562/Adr (229 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

BaF3 (4657 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 475.37Molecular Weight (Monoisotopic): 474.0545AlogP: 3.38#Rotatable Bonds: 4
Polar Surface Area: 123.64Molecular Species: BASEHBA: 9HBD: 3
#RO5 Violations: HBA (Lipinski): 9HBD (Lipinski): 4#RO5 Violations (Lipinski):
CX Acidic pKa: 12.11CX Basic pKa: 9.02CX LogP: 3.50CX LogD: 1.88
Aromatic Rings: 4Heavy Atoms: 31QED Weighted: 0.41Np Likeness Score: -1.93

References

1. Pan X, Liu N, Liu Y, Zhang Q, Wang K, Liu X, Zhang J..  (2022)  Design, synthesis, and biological evaluation of trizole-based heteroaromatic derivatives as Bcr-Abl kinase inhibitors.,  238  [PMID:35561654] [10.1016/j.ejmech.2022.114425]

Source